Michael J Rinaldi
Overview
Explore the profile of Michael J Rinaldi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
2838
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kar S, Price M, Morse M, Rinaldi M, Mahoney P, Denti P, et al.
JACC Cardiovasc Interv
. 2025 Mar;
PMID: 40047747
Background: Treating anterior and bileaflet mitral valve disease in patients with primary or degenerative mitral regurgitation (DMR) is considered more challenging than posterior leaflet repair. Objectives: The aim of this...
2.
Asgar A, Tang G, Rogers J, Rottbauer W, Morse M, Denti P, et al.
JACC Heart Fail
. 2024 Sep;
13(2):213-225.
PMID: 39269396
Background: Moderate secondary mitral regurgitation (SMR) represents a subgroup of heart failure (HF) patients with treatment restricted to medical therapy. Outcomes in patients with moderate SMR treated with mitral transcatheter...
3.
Lerakis S, Kini A, Giustino G, Anastasius M, Asch F, Weissman N, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
3(5):101345.
PMID: 39132458
Background: Transcatheter edge-to-edge repair (TEER) improved outcomes in patients with heart failure (HF) and severe secondary mitral regurgitation (SMR) compared with guideline-directed medical therapy (GDMT) alone regardless of the severity...
4.
Genereux P, Wrobel K, Rinaldi M, Modine T, Bapat V, Ninios V, et al.
Struct Heart
. 2024 May;
8(3):100294.
PMID: 38799804
Background: Treatment options for patients with mitral regurgitation (MR) and mitral annular calcification (MAC) are limited. The limitations of current transcatheter mitral valve replacement (TMVR) technologies include high screen failure...
5.
Dvir D, Tchetche D, Leon M, Genereux P, Seguy B, Makkar R, et al.
Eur Heart J
. 2024 May;
45(33):3031-3041.
PMID: 38747561
Background And Aims: This trial sought to assess the safety and efficacy of ShortCut, the first dedicated leaflet modification device, prior to transcatheter aortic valve implantation (TAVI) in patients at...
6.
Meier D, Grant D, Frawley C, Akodad M, Landes U, Khokhar A, et al.
EuroIntervention
. 2024 Mar;
20(6):e376-e388.
PMID: 38506739
Background: There are limited data regarding treatment for failed balloon-expandable transcatheter heart valves (THVs) in redo-transcatheter aortic valve implantation (TAVI). Aims: We aimed to assess THV performance, neoskirt height and...
7.
Spargias K, Lim D, Makkar R, Kar S, Kipperman R, O Neill W, et al.
Catheter Cardiovasc Interv
. 2023 May;
102(1):145-154.
PMID: 37178388
Background: Mitral valve transcatheter edge-to-edge repair (M-TEER) is an effective option for treatment of mitral regurgitation (MR). We previously reported favorable 2-year outcomes for the PASCAL transcatheter valve repair system....
8.
Shahim B, Redfors B, Stuckey T, Liu M, Zhou Z, Witzenbichler B, et al.
J Am Heart Assoc
. 2022 Dec;
12(1):e026482.
PMID: 36565189
Background Diabetes mellitus and high platelet reactivity (HPR) on clopidogrel are both associated with increased risk of ischemic events after percutaneous coronary intervention, but whether the HPR-associated risk of adverse...
9.
Redfors B, Kirtane A, Liu M, Musikantow D, Witzenbichler B, Rinaldi M, et al.
JACC Cardiovasc Interv
. 2022 Apr;
15(8):797-806.
PMID: 35450679
Objectives: The purpose of this study was to assess the extent to which the association between premature dual antiplatelet therapy (DAPT) discontinuation and excess risk of thrombotic events varies according...
10.
Mohebi R, Galougahi K, Garcia J, Horst J, Ben-Yehuda O, Radhakrishnan J, et al.
JACC Cardiovasc Interv
. 2022 Mar;
15(7):753-766.
PMID: 35305904
Objectives: This study sought to determine correlates and consequences of contrast-associated acute kidney injury (CA-AKI) on clinical outcomes in patients with or without pre-existing chronic kidney disease (CKD). Background: The...